ICAAC 41st Interscience Conference on Antimicrobial Agents and Chemotherapy - Chicago, Ill. Dec 2001
AASLD ( American Association for the Study of Liver Diseases) Conference - Dallas, Texas
Nov 2001
IDSA 2001 39th Meeting of The Infectious Disease Society of America - San Francisco, California
Oct 2001
8th European Conference on Clinical Aspects and Treatment of HIV-Infection (ECCATHI) - Athens, Greece Oct 2001
3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV - Athens, Greece Oct 2001
Reports from the
Selected Recent Developments in HIV Treatment and Research, from Recent Conferences:
(01/10/02)
Reports from the
ICAAC 41st Interscience Conference on Antimicrobial Agents and Chemotherapy
(12/09/01)
Reports from the
IDSA 2001 39th Meeting of The Infectious Disease Society of America San Francisco, California
(10/25/01)
Reports from the
AASLD ( American Association for the Study of Liver Diseases) - Dallas, TX
(11/09/01)
Reports from the
8th European Conference on Clinical Aspects and treatment of HIV-Infection (ECCATHI) - Athens, Greece
(10/28/01)
Reports from the
3rd International Workshop on Adverse Drug reactions and Lipodystrophy in HIV - Athens, Greece
(10/21/01)
Reports from the
AIDS
Vaccine 2001 Conference - Philadelphia, Pennsylvania
(9/7/01)
Reports from the
1st
International AIDS Society Conference on HIV Pathogenesis - Buenos Aires,
Argentina
(7/30/01)
Reports from the
AASLD
Conference:
New
Therapeutic Strategies for Hepatitis C
(6/15/2001)
Reports from the
5th
Resistance Workshop on HIV Drug Resistance & Treatment Strategies
(6/07/2001)
Reports from the
Digestive Disease Week
Liver Conference
(5/22/2001)
Reports from the
7th
Annual Conference of the British HIV Association
also in PDF
format
(4/27/2001)
Report from the
Fourth International
Conference on Nutrition and HIV Infection
Second European Workshop
on Lipodystrophy
Written for NATAP by Graeme Moyle,
MD, MBBS, Chelsea & Westminster Hospital in London, UK
(4/27/2001)
Highlights
from
The 36th Annual
Meeting of EASL (European Association for the Study of
the Liver)
Written
for NATAP by Harvey S. Bartnof, MD Staff Physician at AVERI, AIDS Virus
Education and Research Institute in San Francisco, CA.
(4/21/2001)
Reports for NATAP
from the
2nd International
Workshop on Clinical Pharmacology of HIV Therapy
April
2-4, 2001 Noordwijk, the Netherlands
(4/10/2001)
Jules Levin &
Others Report from the
8th Annual Retrovirus
Conference in Chicago, Illinois, Feb 4-8 2001
(2/5/2001)
